Vanguard Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,378,939
| Closed | -$752K | – | 4152 |
|
|
2016
Q3 | $752K | Sell |
1,378,939
-227,956
| -14% | -$124K | ﹤0.01% | 3651 |
|
|
2016
Q2 | $934K | Sell |
1,606,895
-446,494
| -22% | -$260K | ﹤0.01% | 3624 |
|
|
2016
Q1 | $3M | Buy |
2,053,389
+235,776
| +13% | +$344K | ﹤0.01% | 3209 |
|
|
2015
Q4 | $5.82M | Buy |
1,817,613
+151,206
| +9% | +$484K | ﹤0.01% | 2920 |
|
|
2015
Q3 | $10.4M | Buy |
1,666,407
+66,603
| +4% | +$416K | ﹤0.01% | 2589 |
|
|
2015
Q2 | $15.9M | Buy |
1,599,804
+326,197
| +26% | +$3.24M | ﹤0.01% | 2453 |
|
|
2015
Q1 | $9.39M | Buy |
1,273,607
+54,287
| +4% | +$400K | ﹤0.01% | 2679 |
|
|
2014
Q4 | $6.52M | Buy |
1,219,320
+96,886
| +9% | +$518K | ﹤0.01% | 2752 |
|
|
2014
Q3 | $5.65M | Buy |
1,122,434
+146,575
| +15% | +$737K | ﹤0.01% | 2761 |
|
|
2014
Q2 | $6.55M | Buy |
975,859
+128,231
| +15% | +$860K | ﹤0.01% | 2712 |
|
|
2014
Q1 | $6.14M | Buy |
847,628
+134,370
| +19% | +$973K | ﹤0.01% | 2728 |
|
|
2013
Q4 | $2.69M | Buy |
713,258
+340,567
| +91% | +$1.28M | ﹤0.01% | 3073 |
|
|
2013
Q3 | $1.25M | Buy |
372,691
+2,120
| +0.6% | +$7.11K | ﹤0.01% | 3306 |
|
|
2013
Q2 | $1.24M | Buy |
+370,571
| New | +$1.24M | ﹤0.01% | 3241 |
|